Cargando…

The Level of Surface Coverage of Surgical Site Disinfection Depends on the Visibility of the Antiseptic Agent—A Virtual Reality Randomized Controlled Trial

Background: Surgical site infections (SSIs) have a significant impact on outcome associated with surgical treatment. Therefore, skin antisepsis has evolved as a standard preoperative procedure in the operating room to reduce the perioperative risk of an SSI. In their “Global Guidelines for the preve...

Descripción completa

Detalles Bibliográficos
Autores principales: Burchard, Rene, Sayn, Lukas, Schmidt, Ricardo, Graw, Jan A., Scheicher, Thomas, Soost, Christian, Gruenewald, Armin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961233/
https://www.ncbi.nlm.nih.gov/pubmed/36836006
http://dx.doi.org/10.3390/jcm12041472
_version_ 1784895704132485120
author Burchard, Rene
Sayn, Lukas
Schmidt, Ricardo
Graw, Jan A.
Scheicher, Thomas
Soost, Christian
Gruenewald, Armin
author_facet Burchard, Rene
Sayn, Lukas
Schmidt, Ricardo
Graw, Jan A.
Scheicher, Thomas
Soost, Christian
Gruenewald, Armin
author_sort Burchard, Rene
collection PubMed
description Background: Surgical site infections (SSIs) have a significant impact on outcome associated with surgical treatment. Therefore, skin antisepsis has evolved as a standard preoperative procedure in the operating room to reduce the perioperative risk of an SSI. In their “Global Guidelines for the prevention of surgical site infections”, the World Health Organization (WHO) recommend the use of an agent with remanent additives and considers colored agents as helpful. However, colored and remanent disinfectants are not available in Germany. The aim of the present study was to investigate whether using a colored antiseptic solution increases the quality of preoperative skin antisepsis. Methods: This study was designed as a randomized, double-blinded controlled trial. To examine the level of coverage of skin antisepsis, an appropriate virtual reality (VR) environment was generated. Participants could see a movable surgical clamp with a swab in their hand. When touching the skin, the participants recognized an optical change in the appearance of the skin: Using a colored antiseptic solution resulted in orange-colored skin. Using an uncolored agent, a shiny wet look was visible without a change in natural skin color. Results: Data of 141 participants (female: 61.0% (n = 86); mean age: 28 y (Range 18–58 y, SD = 7.53 y)) were included in the study. The level of disinfection coverage was higher in the group using the colored disinfectant. On average, 86.5% (sd = 10.0) of the leg skin was covered when a colored disinfectant was used, whereas only 73.9% (sd = 12.8) of the leg skin was covered when the participants had to use an uncolored agent (p < 0.001, effect size: f = 0.56, η(2) = 0.24). Conclusions: The use of an uncolored disinfectant leads to a lower surface coverage of the perioperative skin disinfection. Thus far, it is unclear whether using uncolored disinfectants is associated with higher risks for perioperative infections compared with the use of non-remanent disinfectants. Therefore, further research is necessary and current German guidelines should be re-evaluated accordingly.
format Online
Article
Text
id pubmed-9961233
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99612332023-02-26 The Level of Surface Coverage of Surgical Site Disinfection Depends on the Visibility of the Antiseptic Agent—A Virtual Reality Randomized Controlled Trial Burchard, Rene Sayn, Lukas Schmidt, Ricardo Graw, Jan A. Scheicher, Thomas Soost, Christian Gruenewald, Armin J Clin Med Article Background: Surgical site infections (SSIs) have a significant impact on outcome associated with surgical treatment. Therefore, skin antisepsis has evolved as a standard preoperative procedure in the operating room to reduce the perioperative risk of an SSI. In their “Global Guidelines for the prevention of surgical site infections”, the World Health Organization (WHO) recommend the use of an agent with remanent additives and considers colored agents as helpful. However, colored and remanent disinfectants are not available in Germany. The aim of the present study was to investigate whether using a colored antiseptic solution increases the quality of preoperative skin antisepsis. Methods: This study was designed as a randomized, double-blinded controlled trial. To examine the level of coverage of skin antisepsis, an appropriate virtual reality (VR) environment was generated. Participants could see a movable surgical clamp with a swab in their hand. When touching the skin, the participants recognized an optical change in the appearance of the skin: Using a colored antiseptic solution resulted in orange-colored skin. Using an uncolored agent, a shiny wet look was visible without a change in natural skin color. Results: Data of 141 participants (female: 61.0% (n = 86); mean age: 28 y (Range 18–58 y, SD = 7.53 y)) were included in the study. The level of disinfection coverage was higher in the group using the colored disinfectant. On average, 86.5% (sd = 10.0) of the leg skin was covered when a colored disinfectant was used, whereas only 73.9% (sd = 12.8) of the leg skin was covered when the participants had to use an uncolored agent (p < 0.001, effect size: f = 0.56, η(2) = 0.24). Conclusions: The use of an uncolored disinfectant leads to a lower surface coverage of the perioperative skin disinfection. Thus far, it is unclear whether using uncolored disinfectants is associated with higher risks for perioperative infections compared with the use of non-remanent disinfectants. Therefore, further research is necessary and current German guidelines should be re-evaluated accordingly. MDPI 2023-02-12 /pmc/articles/PMC9961233/ /pubmed/36836006 http://dx.doi.org/10.3390/jcm12041472 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Burchard, Rene
Sayn, Lukas
Schmidt, Ricardo
Graw, Jan A.
Scheicher, Thomas
Soost, Christian
Gruenewald, Armin
The Level of Surface Coverage of Surgical Site Disinfection Depends on the Visibility of the Antiseptic Agent—A Virtual Reality Randomized Controlled Trial
title The Level of Surface Coverage of Surgical Site Disinfection Depends on the Visibility of the Antiseptic Agent—A Virtual Reality Randomized Controlled Trial
title_full The Level of Surface Coverage of Surgical Site Disinfection Depends on the Visibility of the Antiseptic Agent—A Virtual Reality Randomized Controlled Trial
title_fullStr The Level of Surface Coverage of Surgical Site Disinfection Depends on the Visibility of the Antiseptic Agent—A Virtual Reality Randomized Controlled Trial
title_full_unstemmed The Level of Surface Coverage of Surgical Site Disinfection Depends on the Visibility of the Antiseptic Agent—A Virtual Reality Randomized Controlled Trial
title_short The Level of Surface Coverage of Surgical Site Disinfection Depends on the Visibility of the Antiseptic Agent—A Virtual Reality Randomized Controlled Trial
title_sort level of surface coverage of surgical site disinfection depends on the visibility of the antiseptic agent—a virtual reality randomized controlled trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961233/
https://www.ncbi.nlm.nih.gov/pubmed/36836006
http://dx.doi.org/10.3390/jcm12041472
work_keys_str_mv AT burchardrene thelevelofsurfacecoverageofsurgicalsitedisinfectiondependsonthevisibilityoftheantisepticagentavirtualrealityrandomizedcontrolledtrial
AT saynlukas thelevelofsurfacecoverageofsurgicalsitedisinfectiondependsonthevisibilityoftheantisepticagentavirtualrealityrandomizedcontrolledtrial
AT schmidtricardo thelevelofsurfacecoverageofsurgicalsitedisinfectiondependsonthevisibilityoftheantisepticagentavirtualrealityrandomizedcontrolledtrial
AT grawjana thelevelofsurfacecoverageofsurgicalsitedisinfectiondependsonthevisibilityoftheantisepticagentavirtualrealityrandomizedcontrolledtrial
AT scheicherthomas thelevelofsurfacecoverageofsurgicalsitedisinfectiondependsonthevisibilityoftheantisepticagentavirtualrealityrandomizedcontrolledtrial
AT soostchristian thelevelofsurfacecoverageofsurgicalsitedisinfectiondependsonthevisibilityoftheantisepticagentavirtualrealityrandomizedcontrolledtrial
AT gruenewaldarmin thelevelofsurfacecoverageofsurgicalsitedisinfectiondependsonthevisibilityoftheantisepticagentavirtualrealityrandomizedcontrolledtrial
AT burchardrene levelofsurfacecoverageofsurgicalsitedisinfectiondependsonthevisibilityoftheantisepticagentavirtualrealityrandomizedcontrolledtrial
AT saynlukas levelofsurfacecoverageofsurgicalsitedisinfectiondependsonthevisibilityoftheantisepticagentavirtualrealityrandomizedcontrolledtrial
AT schmidtricardo levelofsurfacecoverageofsurgicalsitedisinfectiondependsonthevisibilityoftheantisepticagentavirtualrealityrandomizedcontrolledtrial
AT grawjana levelofsurfacecoverageofsurgicalsitedisinfectiondependsonthevisibilityoftheantisepticagentavirtualrealityrandomizedcontrolledtrial
AT scheicherthomas levelofsurfacecoverageofsurgicalsitedisinfectiondependsonthevisibilityoftheantisepticagentavirtualrealityrandomizedcontrolledtrial
AT soostchristian levelofsurfacecoverageofsurgicalsitedisinfectiondependsonthevisibilityoftheantisepticagentavirtualrealityrandomizedcontrolledtrial
AT gruenewaldarmin levelofsurfacecoverageofsurgicalsitedisinfectiondependsonthevisibilityoftheantisepticagentavirtualrealityrandomizedcontrolledtrial